For carriers of pathogenic variants in BRCA1 and BRCA2 with a personal history of breast cancer, bilateral ...

Cambridge researchers have shown that removing the ovaries and fallopian tubes of women with breast cancer who carry certain ...

Overall survival (OS) in BRCA -mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to ...

Both the World Health Organization and the American Academy of Pediatrics recommend that infants exclusively breastfeed during their first six months of life, but only 24.9% in the United States do, ...

First site initiated for Phase 3 OVATION 3 study of IMNN-001 in treatment of newly diagnosed advanced ovarian cancer New data from Phase 2 OVATION 2 study of IMNN-001 accepted for oral presentation at ...

Stacy Lindborg; President, Chief Executive Officer and Board Director; Imunon Inc. Presentation. Operator. Good morning. My name is Dave, and I will be your operator ...

So, the data do warrant confirmatory trials, but those trials need to also include immunotherapy." The discovery that single-agent PARP inhibition could selectively kill BRCA1/2-deficient cancer ...

In the middle of the night Sali Sasi would wake in a pool of sweat, feeling as if hundreds of insects were crawling under her ...

May 7, 2025 — Women diagnosed with breast cancer who carry particular BRCA1 and BRCA2 genetic variants ... A new analysis of data from the Women's Health Initiative found that estrogen-based ...